NSN 6505-01-340-4829

Part Details | USP CLONAZEPAM TABLETS

6505-01-340-4829

Alternate Parts: NDC00228300411, NDC00228-3004-11, NDC57664027408, NDC57664-0274-08, NDC00591074701, NDC00591-0747-01, NDC00185006401, NDC00185-0064-01, NDC60505006701, NDC60505-0067-01, NDC00182822989, NDC00182-8229-89, NDC00004005801, NDC00004-0058-01, NDC00093083301, NDC00093-0833-01, NDC00904534360, NDC00904-5343-60, NDC51079088221, NDC51079-0882-21, NDC51079088201, NDC51079-0882-01, NDC00378191201, NDC00378-1912-01, NDC00185006401, NDC00185-0064-01, 6505-01-340-4829, 01-340-4829, 6505013404829, 013404829

Supply Group (FSG) NSN Assigned NIIN Item Name Code (INC)
65JUN 13, 199101-340-482933952 ( CLONAZEPAM TABLETS, USP )
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-340-4829
Part Number Cage Code Manufacturer
NDC00228-3004-1156287ACTAVIS ELIZABETH LLCDBA ACTAVIS US
NDC57664-0274-080PUV4CARACO PHARMACEUTICAL LABORATORIES,LTD.
NDC00591-0747-0162051DANBURY PHARMACAL INC
NDC00185-0064-010WTU2EON LABS INC.
NDC60505-0067-011VZL6FALCON PHARMACEUTICALS LTD
NDC00182-8229-8963488GOLDLINE LABORATORIES INC.DBA GOLDLINE LABORATORIES
NDC00004-0058-0104493HOFFMANN-LA ROCHE INC.
NDC00093-0833-0180608LEMMON CO
NDC00904-5343-600SYT3MAJOR PHARMACEUTICALS INC
NDC51079-0882-2165751MYLAN INSTITUTIONAL INC.
NDC51079-0882-0165751MYLAN INSTITUTIONAL INC.
NDC00378-1912-0160895MYLAN PHARMACEUTICALS INC
NDC00185-0064-010THL4SANDOZ INC.
Technical Data | NSN 6505-01-340-4829
Characteristic Specifications
ACTIVE MEDICAMENT MEDICINAL STRENGTHAB1.000 MILLIGRAMS CLONAZEPAM
PRIMARY CONTAINER TYPE STRIP, REVERSE NUMBERED
PRIMARY CONTAINER CONTENT QUANTITY25.000 TABLETS
TOTAL PRIMARY CONTAINER QUANTITY4
FEATURES PROVIDED INDIVIDUALLY SEALED
SPECIAL FEATURESUNIT DOSE; REVERSE NUMBER PACK
PROTECTIVE STORAGE FEATURE SECURITY STORAGE
PART NAME ASSIGNED BY CONTROLLING AGENCYCLONAZEPAM TABLETS USP 1MG I.S. 100S PG